Artificial Intelligence (AI) for Programmed Death Ligand-1 (PD-L1) Immunohistochemical Assessment in Urothelial Carcinomas: “Teaching” Cell Differentiation to AI Systems. This evidence concerns the gene CD274 and urothelial carcinoma.